VAXNEUVANCE 30 ug/.5mL

VAXNEUVANCE 30 ug/0.5mL is a pneumococcal 15-valent conjugate vaccine designed for intramuscular administration. It helps protect against pneumococcal diseases caused by 15 serotypes. This vaccine is suitable for individuals at risk of pneumococcal infections.

VAXNEUVANCE 30 ug/0.5mL is used to prevent pneumococcal diseases, including pneumonia, bacteremia, and meningitis. It is particularly important for individuals who are at higher risk of pneumococcal infections, such as those with weakened immune systems or chronic health conditions. The vaccine works by stimulating the body's immune response to protect against specific serotypes of the pneumococcus bacteria.

Common effects of VAXNEUVANCE 30 ug/0.5mL may include mild to moderate reactions at the injection site, such as redness, swelling, and pain. Some individuals may also experience temporary systemic effects like fatigue, headache, or muscle pain. These effects are generally short-lived and resolve on their own.

VAXNEUVANCE 30 ug/0.5mL should be administered by healthcare professionals trained in intramuscular injections. It is important to inform your healthcare provider about any allergies or medical conditions before receiving the vaccine. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid it.

VAXNEUVANCE 30 ug/0.5mL may interact with certain medications or other vaccines. It is advisable to discuss your current medications and vaccination schedule with your healthcare provider to avoid potential interactions. Alcohol and other immune-suppressing substances may affect the vaccine's effectiveness.